SW
RMD icon

SkyOak Wealth’s ResMed RMD Stock Holding History

SkyOak Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
1,332
+411
+45% +$85.2K 0.04% 201
2026
Q1 		$207K Sell
921
-81
-8% -$20.2K 0.04% 238
2025
Q4 		$241K Sell
1,002
-42
-4% -$10.7K 0.04% 213
2025
Q3 		$286K Sell
1,044
-40
-4% -$10.9K 0.05% 195
2025
Q2 		$280K Hold
1,084
– – 0.06% 187
2025
Q1 		$243K Buy
+1,084
New +$253K 0.05% 202

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SkyOak Wealth's RMD Position: Q2 2026 in Review

SkyOak Wealth increased its ResMed (RMD) stake by 45% in Q2 2026, buying an estimated $85.2K and bringing the position to 1,332 shares worth $260K. The position accounts for 0.04% of the portfolio, ranked #201.

SkyOak Wealth first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $286K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SkyOak Wealth held 1,332 shares of ResMed worth $260K as of Q2 2026.
  • SkyOak Wealth bought 411 ResMed shares in Q2 2026, an estimated $85.2K.
  • ResMed made up 0.04% of SkyOak Wealth's portfolio in Q2 2026, its #201 holding.
  • SkyOak Wealth first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • SkyOak Wealth's ResMed position peaked at $286K in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SkyOak Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.